Integra Therapeutics has introduced its core values, a set of principles that will guide the company’s internal culture as well as its business and scientific activities as it continues to develop pioneering advances in the field of gene-writing.

The core values were defined through a collaborative process involving the entire team, including a series of workshops led by expert Alicia Marín Muniesa. During these sessions, participants reflected on the principles that should guide the organization’s day-to-day work as well as its broader impact on society. The outcome is a framework built around four key pillars:

• Team well-being
• Passion for innovation
• Pursuit of excellence
• Sustainability to protect the planet

For Integra Therapeutics, prioritizing team well-being is essential to building an environment where scientific creativity and innovation can flourish. The company also highlights the importance of striving for excellence in every project and integrating sustainability into decision-making, ensuring that technological progress goes hand in hand with environmental responsibility.

Integra Therapeutics has developed a pioneering gene-writing technology, FiCAT, designed to expand the capabilities of genetic engineering and open new therapeutic possibilities. Within this context, the newly defined core values reinforce the team’s commitment to an ambitious mission: advancing a new generation of cell and gene therapies with the potential to transform the future of medicine.